LIC MF Healthcare Fund-Regular Plan-Growth

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 30.1782 ↑ 0.42%
[as on 20 October, 2025]

NAV chart with SMA (Simple moving average) overlay

SMA (Simple Moving Average)

  • 100 SMA
  • 200 SMA
  • 300 SMA
  • 400 SMA
  • 500 SMA

Returns

NameYTD1D1W1M3M1Y3Y5Y7Y10Y
LIC MF Healthcare Fund-Regular Plan-Growth -1.14% 0.42% 0.99% 0.41% 0.91% 0.49%----

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
97.82% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 2.18%

Equity

NameSectorWeight %
Sun Pharmaceutical Industries Ltd.Pharmaceuticals & Biotechnology10.08%
Apollo Hospitals Enterprise Ltd.Healthcare Services5.85%
Torrent Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology5.55%
Cipla Ltd.Pharmaceuticals & Biotechnology5.51%
Fortis Healthcare Ltd.Healthcare Services4.79%
Piramal Pharma Ltd.Pharmaceuticals & Biotechnology4.45%
Neuland Laboratories Ltd.Pharmaceuticals & Biotechnology4.14%
Divi's Laboratories Ltd.Pharmaceuticals & Biotechnology4.11%
Aurobindo Pharma Ltd.Pharmaceuticals & Biotechnology3.98%
Alkem Laboratories Ltd.Pharmaceuticals & Biotechnology3.96%
Abbott India Ltd.Pharmaceuticals & Biotechnology3.33%
Gland Pharma Ltd.Pharmaceuticals & Biotechnology3.12%
Artemis Medicare Services Ltd.Healthcare Services2.99%
Dr Agarwal's Health Care Ltd.Healthcare Services2.96%
IPCA Laboratories Ltd.Pharmaceuticals & Biotechnology2.88%
Glenmark Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology2.75%
Metropolis Healthcare Ltd.Healthcare Services2.73%
Onesource Specialty Pharma Ltd.Pharmaceuticals & Biotechnology2.61%
Navin Fluorine International Ltd.Chemicals & Petrochemicals2.60%
Mankind Pharma Ltd.Pharmaceuticals & Biotechnology2.45%
Concord Biotech Ltd.Pharmaceuticals & Biotechnology2.39%
Global Health Ltd.Healthcare Services2.31%
Max Healthcare Institute Ltd.Healthcare Services2.19%
Syngene International Ltd.Healthcare Services2.07%
JB Chemicals & Pharmaceuticals Ltd.Pharmaceuticals & Biotechnology1.95%
Vinati Organics Ltd.Chemicals & Petrochemicals1.78%
Anthem Biosciences Ltd.Pharmaceuticals & Biotechnology1.65%
Acutaas Chemicals Ltd.Pharmaceuticals & Biotechnology1.50%
Linde India Ltd.Chemicals & Petrochemicals1.14%
Portfolio data is as on date 30 September, 2025

NAV (Net asset value) history

LIC MF Healthcare Fund-Regular Plan-Growth - 30 days NAV history

DateNAV
20 October, 202530.1782
17 October, 202530.0515
16 October, 202529.9321
15 October, 202529.7907
14 October, 202529.7461
13 October, 202529.8814
10 October, 202529.9675
9 October, 202529.6343
8 October, 202529.4501
7 October, 202529.605
6 October, 202529.4621
3 October, 202529.1478
1 October, 202529.251
30 September, 202529.0119
29 September, 202528.9269
26 September, 202528.8106
25 September, 202529.2829
24 September, 202529.4387
23 September, 202529.611
22 September, 202529.7697
19 September, 202530.0561
18 September, 202529.9656
17 September, 202529.762
16 September, 202529.7793
15 September, 202529.711
12 September, 202529.7618
11 September, 202529.6956
10 September, 202529.5462
9 September, 202529.3844
8 September, 202529.3076

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of LIC MF Healthcare Fund-Regular Plan-Growth?
    The latest NAV of LIC MF Healthcare Fund-Regular Plan-Growth is 30.1782 as on 20 October, 2025.
  • What are YTD (year to date) returns of LIC MF Healthcare Fund-Regular Plan-Growth?
    The YTD (year to date) returns of LIC MF Healthcare Fund-Regular Plan-Growth are -1.14% as on 20 October, 2025.
  • What are 1 year returns of LIC MF Healthcare Fund-Regular Plan-Growth?
    The 1 year returns of LIC MF Healthcare Fund-Regular Plan-Growth are 0.49% as on 20 October, 2025.